1.12
price down icon8.94%   -0.11
after-market After Hours: 1.13 0.010 +0.89%
loading

Salarius Pharmaceuticals Inc Stock (SLRX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
82.51%
1.7716
0.9707 2.5322 3.9714 5.4207
Operating Income/Loss
82.51%
-1.7716
-0.9707 -2.5322 -3.9714 -5.4207
Income/Loss From Continuing Operations Before Tax
94.52%
-1.7153
-0.8818 -2.4428 -3.8773 -5.3408
Income/Loss From Continuing Operations After Tax
94.52%
-1.7153
-0.8818 -2.4428 -3.8773 -5.3408
Net Income/Loss
94.52%
-1.7153
-0.8818 -2.4428 -3.8773 -5.3408
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,747%
4.1946
0.2271 3.754 2.7091 2.392
Diluted Average Shares
1,747%
4.1946
0.2271 3.754 2.7091 2.392
Basic Earnings Per Share
-0.41
- -0.65 -1.43 -2.23
Diluted Earnings Per Share
-0.41
- -0.65 -1.43 -2.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):